Copyright
©The Author(s) 2022.
World J Psychiatry. Sep 19, 2022; 12(9): 1183-1193
Published online Sep 19, 2022. doi: 10.5498/wjp.v12.i9.1183
Published online Sep 19, 2022. doi: 10.5498/wjp.v12.i9.1183
Figure 1 Transforming growth factor-beta and galectin-3 levels impact the illness.
A: Lower transforming growth factor-beta (TGF-β) levels (272.09 ± 101.59 vs 360.41 ± 45.13 pg/mL, P = 0.003) were measured in patients; B: These parameters of serum concentrations of galectin-3 and TGF-β both had an impact on disease presentation. TGF-β: Transforming growth factor-beta; IL: Interleukin; Gal-3: Galectin-3.
- Citation: Minic Janicijevic S, Jovanovic IP, Gajovic NM, Jurisevic MM, Debnath M, Arsenijevic NN, Borovcanin MM. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World J Psychiatry 2022; 12(9): 1183-1193
- URL: https://www.wjgnet.com/2220-3206/full/v12/i9/1183.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i9.1183